弥漫性肺部感染临床诊治分析

目的 探讨分析阿奇霉素治疗弥漫性肺部感染临床治疗效果.方法 选取2010年1月-2012年12月该院收治的80例肺部感染的患者为研究对象,随机将患者分为观察组和对照组,每组40例患者,其中观察组患者采用阿奇霉素静脉滴注进行治疗,对照组患者静脉滴注阿莫西林进行治疗,观察两组患者临床疗效、不良反应率以及住院时间的差异.结果 观察组患者的临床显效率为95％,对照组患者的临床显效率为72.5％,两组患者临床治疗效果差异有统计学意义（P＜0.05）,观察组患者的临床不良反应率为7.5％,对照组患者不良反应率为20％,两组患者临床不良反应率差异有统计学意义（P＜0.05）.结论 采用阿奇霉素静脉滴注治疗弥漫性肺部感染安全有效,可有效缩短临床用药时间,提高患者治疗效果,值得在临床上应用.

The Analysis of Clinical Diagnosis and Treatment of Diffuse Pulmonary Infection

Objective To study the clinical effects of Azithromycin on diffuse pulmonary infection. Methods 80 patients with pul- monary infection admitted in our hospital from January, 2010 to December, 2012 were selected and randomly divided into observa- tion group and control group with 40 patients in each. The observation group was treated with azithromycin intravenously, and the control group was treated with amoxicillin intravenously. The efficacy, adverse reaction rate and length of stay of the groups were observed and compared. Results The effective rate of the observation group was 95%, while that of the control group was 72.5%, the difference was statistically significant （P〈0.05）. The adverse reaction rate of the observation group was 7.5%, lower than the control group＇s 20%, the difference was statistically significant （P〈0.05）. Conclusion Azithromycin is safe and effective in treating diffuse pulmonary infection, which can obviously shorten the time of treatment, improve the efficacy of treatment and deserves clinical application.